CAMP LEJEUNE, N.C. — When lives are on the line, every second counts. Maintaining a modernized force is at the forefront of Force Design and standardizing equipment that meets critical medical care needs is more than essential in ensuring lives are saved when it matters most.
For the first time in 20 years, the Marine Corps is fielding a fully modernized medical capability to the Fleet Marine Force, marking a major step forward in how the service sustains and saves lives in austere combat environments.
The rollout marks the Initial Operational Capability (IOC) fielding and turnover of the newly modernized Damage Control Resuscitation (DCR) and Damage Control Surgery (DCS) systems. Managed under Portfolio Acquisition Executive Marine Corps (PAE MC), the effort demonstrates the Marine Corps’ ability to rapidly deliver relevant, mission-ready capabilities directly to the warfighter.
The systems, comprised of the Authorized Medical Allowance Lists (AMAL) 700 DCR and AMAL 705 DCS, provide a lightweight, expeditionary Role 2 medical capability designed for distributed and contested environments. The equipment enables commanders to deliver far-forward resuscitative care and limited surgical intervention in locations where traditional medical evacuation may be delayed or unavailable.
“The strategic environment demands agility and velocity. PAE MC is delivering exactly that to the Fleet Marine Force. By fielding the modernized AMAL 700 and 705 systems, we are providing a man-portable Role 2 capability. This equipment pushes life-saving resuscitative and surgical care further forward to support Expeditionary Advanced Base Operations.” Lt. Col. Aaron Viana, product manager for PdM Combat Service Support Equipment (PdM CSSE)
Before the systems are formally integrated into the fleet, Marines and civilians across multiple organizations are conducting a detailed verification and turnover process.
Personnel from the receiving unit, 2nd Combat Readiness Regiment (CRR), are working alongside Medical Logistics Company (MEDLOGCO) and Product Manager Combat Service Support Equipment (PdM CSSE) teams to ensure every component is accounted for and fully mission capable.
Together, the teams are conducting joint inventories and Limited Technical Inspections (LTIs) to verify operational readiness across the entire equipment set. The process ensures every medical device, supply, and subsystem is functional and ready for immediate deployment.
Key improvements to the legacy systems include a greater control on life-threatening hemorrhage, treatment for hemorrhage shock, emergency resuscitative care, limited life-saving surgical procedures and the ability to sustain critically wounded patients during extended evacuation times.
For the Marines and medical personnel who will rely on these systems during distributed maritime operations and expeditionary deployments, this modernization represents a significant improvement over legacy equipment that has remained largely unchanged for decades.
“It’s about delivering integrated combat power, and ultimately, saving Marines’ lives in contested environments,” said Viana.
The coordinated effort between program offices, logisticians, and operational units reflects a focus on delivering modern, expeditionary capabilities to the force. As fielding continues across the Marine Corps, the AMAL 700 and 705 systems are expected to significantly improve survivability and medical support at the tactical edge.
By Kristiana Gehly | PEO Land Systems
